P/B ratio

Search documents
CON vs. MEDP: Which Stock Is the Better Value Option?
ZACKS· 2025-03-06 17:45
Core Viewpoint - The comparison between Concentra Group (CON) and Medpace (MEDP) indicates that CON presents a better value opportunity for investors at this time [1]. Group 1: Zacks Rank and Earnings Outlook - CON has a Zacks Rank of 2 (Buy), while MEDP has a Zacks Rank of 3 (Hold), suggesting that CON is likely experiencing a more favorable earnings outlook [3]. - The Zacks Rank focuses on companies with positive earnings estimate revisions, which is a key factor for value investors [2]. Group 2: Valuation Metrics - CON has a forward P/E ratio of 17.37, compared to MEDP's forward P/E of 26.73, indicating that CON may be undervalued relative to MEDP [5]. - The PEG ratio for CON is 2.08, while MEDP's PEG ratio is 3.63, further suggesting that CON has a more attractive valuation based on expected earnings growth [5]. - CON's P/B ratio is 10.37, whereas MEDP's P/B ratio is 12.37, reinforcing the notion that CON is more favorably valued [6]. Group 3: Value Grades - CON has a Value grade of B, while MEDP has a Value grade of C, indicating that CON is perceived as a better value investment [6].
Are Investors Undervaluing Everi (EVRI) Right Now?
ZACKS· 2025-03-06 15:45
Core Viewpoint - The article emphasizes the importance of value investing and highlights Everi (EVRI) as a strong candidate for value investors due to its favorable valuation metrics and earnings outlook [2][3][6]. Valuation Metrics - Everi has a Price-to-Book (P/B) ratio of 4.70, which is attractive compared to the industry average of 5.14. The P/B ratio has fluctuated between 2.32 and 4.73 over the past 52 weeks, with a median of 4.46 [4]. - The Price-to-Cash Flow (P/CF) ratio for Everi is 6.61, significantly lower than the industry average of 13.87. This ratio has ranged from 2.62 to 6.65 in the past year, with a median of 5.75 [5]. Investment Outlook - Everi holds a Zacks Rank of 2 (Buy) and an "A" grade in the Value category, indicating it is among the strongest value stocks currently available in the market [3][6].
BDORY or UOVEY: Which Is the Better Value Stock Right Now?
ZACKS· 2025-02-27 17:40
Core Viewpoint - Investors in the Banks - Foreign sector should consider Banco Do Brasil SA (BDORY) and United Overseas Bank Ltd. (UOVEY) for potential value opportunities [1] Valuation Metrics - Banco Do Brasil SA has a Zacks Rank of 1 (Strong Buy), indicating a positive earnings outlook, while United Overseas Bank Ltd. has a Zacks Rank of 3 (Hold) [3] - BDORY has a forward P/E ratio of 4.34, significantly lower than UOVEY's forward P/E of 10.44, suggesting BDORY may be undervalued [5] - The PEG ratio for BDORY is 1.55, compared to UOVEY's PEG ratio of 1.81, indicating BDORY has a more favorable growth outlook relative to its valuation [5] - BDORY's P/B ratio is 0.81, while UOVEY's P/B ratio is 1.37, further supporting the argument that BDORY is undervalued [6] - Based on various valuation metrics, BDORY holds a Value grade of A, whereas UOVEY has a Value grade of C [6] Conclusion - BDORY has demonstrated stronger estimate revision activity and more attractive valuation metrics than UOVEY, making it a more appealing option for value investors [7]
PYPL vs. MA: Which Stock Is the Better Value Option?
ZACKS· 2025-02-26 17:45
Investors looking for stocks in the Financial Transaction Services sector might want to consider either Paypal (PYPL) or MasterCard (MA) . But which of these two stocks is more attractive to value investors? We'll need to take a closer look to find out.Everyone has their own methods for finding great value opportunities, but our model includes pairing an impressive grade in the Value category of our Style Scores system with a strong Zacks Rank. The proven Zacks Rank puts an emphasis on earnings estimates an ...